Wound and surgical sealant company HyperBranch Medical Technology, moving to commercialize a new sealant technology in Europe and secure regulatory clearance in the United States, has raised $1.7 million in equity financing. The securities offering started on May 25 — 10 days after the company announced it had received a CE Mark for its spray […]
Wound and surgical sealant developer HyperBranch Medical Technology has received the CE Mark for an applicator that delivers its sealant used in cranial and spinal surgeries. The Adherus AutoSpray Dural Sealant delivers HyperBranch’s dural sealant to prevent leaks of cerebrospinal fluid after the surgical repair. The company’s spinal sealant had previously secured a CE Mark. […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Wound and surgical sealant company HyperBranch Medical Technology has developed a gel intended as a sealant for brain and spinal procedures. The company is in the midst of clinical testing to see if it works as well as a sealant from Covidien (NYSE:COV). Durham, North Carolina-based HyperBranch now has some more cash to help in […]